Compounds > vatalanib
Page last updated: 2024-09-04

vatalanib and chir 99021

vatalanib has been researched along with chir 99021 in 1 studies

Compound Research Comparison

Studies
(vatalanib)		Trials
(vatalanib)		Recent Studies (post-2010)
(vatalanib)		Studies
(chir 99021)		Trials
(chir 99021)		Recent Studies (post-2010) (chir 99021)
27642982721258

Protein Interaction Comparison

ProteinTaxonomyvatalanib (IC50)chir 99021 (IC50)
G2/mitotic-specific cyclin-B2Homo sapiens (human)8.8
Cyclin-dependent kinase 1Homo sapiens (human)8.8
G2/mitotic-specific cyclin-B1Homo sapiens (human)8.8
Glycogen synthase kinase-3 alphaHomo sapiens (human)0.0089
Glycogen synthase kinase-3 betaHomo sapiens (human)0.0133
G2/mitotic-specific cyclin-B3Homo sapiens (human)8.8

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hajduk, PJ; Johnson, EF; Kifle, L; Merta, PJ; Metz, JT; Soni, NB1

Other Studies

1 other study(ies) available for vatalanib and chir 99021

ArticleYear
Navigating the kinome.
    Nature chemical biology, 2011, Volume: 7, Issue:4

    Topics: Drug Design; Pharmacogenetics; Protein Kinases; Proteome; Systems Biology

2011